176 related articles for article (PubMed ID: 1386353)
1. Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.
Carreno M; Fuller L; Zucker K; Yang WC; Burke G; Nery J; Gomez C; Esquenazi V; Miller J
Hum Immunol; 1992 Apr; 33(4):249-58. PubMed ID: 1386353
[TBL] [Abstract][Full Text] [Related]
2. OKT3 induction via idiotypic networks of mirror-image immunosuppressive antiimmunoglobulins in renal transplant recipients.
Carreno M; Yang WC; Esquenazi V; Fuller L; Burke G; Milgrom M; Roth D; Ranjan D; Miller J
Transplantation; 1990 Feb; 49(2):408-15. PubMed ID: 1689519
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
[TBL] [Abstract][Full Text] [Related]
4. Detection of IGA anti-OKT3 antibodies in OKT3-treated transplant recipients.
McIntyre JA; Kincade M; Higgins NG
Transplantation; 1996 May; 61(10):1465-9. PubMed ID: 8633372
[TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA.
Regan J; Campbell K; van Smith L; Pouletty P; Schroeder TJ; Guttmann RD; Buelow R
Transpl Immunol; 1997 Mar; 5(1):49-56. PubMed ID: 9106335
[TBL] [Abstract][Full Text] [Related]
6. Evidence that antibodies to cytomegalovirus and the T cell receptor (TCR)/CD3 complex may have common ligands.
Yang WC; Carreno M; Esquenazi V; Fuller L; Ranjan D; Burke G; Roth D; Miller J
Transplantation; 1991 Feb; 51(2):490-8. PubMed ID: 1847253
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
8. Immunologic monitoring with Orthoclone OKT3 therapy.
Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
[TBL] [Abstract][Full Text] [Related]
9. Thymus-dependent antiidiotype and anti-antiidiotype responses to a dinitrophenyl-specific monoclonal antibody.
Baskin JG; Ryan TM; Vakil M; Kearney JF; Lamon EW
J Immunol; 1990 Jul; 145(1):202-8. PubMed ID: 2358673
[TBL] [Abstract][Full Text] [Related]
10. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).
Bhattacharya-Chatterjee M; Chatterjee SK; Vasile S; Seon BK; Kohler H
J Immunol; 1988 Aug; 141(4):1398-403. PubMed ID: 2899603
[TBL] [Abstract][Full Text] [Related]
11. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
Woodle ES; Thistlethwaite JR; Jolliffe LK; Zivin RA; Collins A; Adair JR; Bodmer M; Athwal D; Alegre ML; Bluestone JA
J Immunol; 1992 May; 148(9):2756-63. PubMed ID: 1533410
[TBL] [Abstract][Full Text] [Related]
12. Idiotypic analysis of anti-I-Ak monoclonal antibodies. III. T- and B-cell responses to anti-Ia idiotopes are not modulated by syngeneic anti-idiotypic monoclonal antibodies.
Phillips ML; Delovitch TL
Cell Immunol; 1985 Dec; 96(2):363-75. PubMed ID: 3879805
[TBL] [Abstract][Full Text] [Related]
13. T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.
Gebel HM; Lebeck LK; Jensik SC; Webster K; Bray RA
Hum Immunol; 1989 Oct; 26(2):123-9. PubMed ID: 2479623
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
15. The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transpl Immunol; 1995 Sep; 3(3):212-21. PubMed ID: 8581409
[TBL] [Abstract][Full Text] [Related]
16. Variation in patient response associated with different preparations of murine monoclonal antibody therapy.
Delmonico FL; Fuller TC; Russell PS; Colvin RB; Cosimi AB
Transplantation; 1989 Jan; 47(1):92-5. PubMed ID: 2521411
[TBL] [Abstract][Full Text] [Related]
17. Successful retreatment of allograft rejection with OKT3.
First MR; Schroeder TJ; Hurtubise PE; Mansour ME; Penn I; Munda R; Balistreri WF; Alexander JW; Melvin DB; Fidler JP
Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
Comacchio RM; Bradley J; Hohmann AW
Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
[TBL] [Abstract][Full Text] [Related]
19. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
[TBL] [Abstract][Full Text] [Related]
20. Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipients.
Niaudet P; Jean G; Broyer M; Chatenoud L
Pediatr Nephrol; 1993 Jun; 7(3):263-7. PubMed ID: 8518095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
